Cytokines in the pathogenesis of cancer cachexia
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 6 (4) , 401-406
- https://doi.org/10.1097/01.mco.0000078983.18774.cc
Abstract
The aim of the present review is to summarize and update the role of different cytokines in the pathogenesis of cancer cachexia and to provide therapeutic strategies based on cytokine action. Cancer cachexia is a syndrome characterized by a marked weight loss, anorexia, asthenia and anemia. The cachectic state is invariably associated with the presence and growth of the tumor and leads to a malnutrition status due to the induction of anorexia or decreased food intake. In addition, the competition for nutrients between the tumor and the host leads to an accelerated starvation state which promotes severe metabolic disturbances in the host, including hypermetabolism, which leads to an increased energetic inefficiency. Different cytokines are clearly implicated in this process, possibly being responsible for anorexia, hypermetabolism and many other metabolic abnormalities, such as muscle proteolysis and apoptosis. Although the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. A lot of progress has been made, however, in understanding the role of different cytokines - tumor necrosis factor and IL-6 in particular - in muscle wasting associated with cancer cachexia, perhaps the most paradigmatic feature of this complex syndrome.Keywords
This publication has 42 references indexed in Scilit:
- Cancer cachexiaInternational Journal of Cardiology, 2002
- CANCER CACHEXIA IS MEDIATED IN PART BY THE INDUCTION OF IL-6-LIKE CYTOKINES FROM THE SPLEENCytokine, 2001
- Suppression of Tumor Necrosis Factor-mediated Apoptosis by Nuclear Factor κB-independent Bone Morphogenetic Protein/Smad SignalingPublished by Elsevier ,2001
- ROLE OF CYTOKINES IN CANCER CACHEXIA IN A MURINE MODEL OF INTRACEREBRAL INJECTION OF HUMAN TUMOURSCytokine, 2001
- Potential Novel Uses of ThalidomideDrugs, 2000
- A Model that Reproduces Syndromes Associated with Human Multiple Myeloma in Nonirradiated SCID MiceProceedings of the Society for Experimental Biology and Medicine, 2000
- In the rat, tumor necrosis factor α administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine‐induced thermogenesis?FEBS Letters, 1998
- Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing ratsLife Sciences, 1994
- Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.Journal of Clinical Investigation, 1993
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991